Get 20% lifetime commission for referring investors to digrin.com
here.
Eledon Pharmaceuticals, Inc. ( ELDN) - Key Metrics
ELDN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.28 | -$0.20 | -$0.20 |
| 2026Q1 | $0 | -$0.35 | -$0.20 | -$0.20 |
| 2025Q4 | $0 | -$0.14 | -$0.19 | -$0.19 |
| 2025Q3 | $0 | -$0.23 | -$0.19 | -$0.19 |
| 2025Q2 | $0 | -$0.15 | -$0.23 | -$0.23 |
ELDN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.65 |
| 2026Q1 | 0% | -2.20 |
| 2025Q4 | 0% | -2.70 |
| 2025Q3 | 0% | -2.82 |
| 2025Q2 | 0% | -4.52 |
ELDN
Price: $3.62
52 week price:
Earnings Per Share: -0.90 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 24400
Market Capitalization: 287.7 million